Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Active-controlled, Open Label, 2-treatment Arm, and Multicenter Study Comparing the Efficacy and Safety of the Insulin Glargine/Lixisenatide Combination to Insulin Glargine on Top of OADs in Japanese Patients With Type 2 Diabetes Mellitus (T2DM)

NCT02752828 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT02752828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02752828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Active-controlled, Open Label, 2-treatment Arm, and Multicenter Study Comparing the Efficacy and Safety of the Insulin Glargine/Lixisenatide Combination to Insulin Glargine on Top of OADs in Japanese Patients With Type 2 Diabetes Mellitus (T2DM)
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
May 23, 2016
Completion date
March 12, 2018
Enrollment
521 (actual)
Sites
113

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus